Zum Inhalt

HealthOSArzneimittel

Arbeitsbereiche

Nachschlagen

Wirkstoffe & Arzneimittelsicherheit

Exakte Wirkstoffkennungen und zitierbare Passagen zu Wechselwirkungen, Gegenanzeigen und Nebenwirkungen.

Ein Paarvergleich findet Originalpassagen, die den anderen Wirkstoff wörtlich nennen. Aussagen gelten für das jeweilige Präparat und seine Formulierung. Klassenbegriffe und abweichende Synonyme können fehlen. Kein Treffer bedeutet nicht, dass keine Wechselwirkung besteht.

RxNorm 05-Oct-2026 · geprüft 2026-10-25 · 96 Präparate · 6744 Quellenpassagen. Automatisch aktualisiert, ohne menschliche Freigabe.

Quellenpassagen (1)

Nebenwirkungen · Remicade

Remicade 100 mg powder for concentrate for solution for infusion. · Abschnitt 4.8 · PDF-Seite 14–15

HOS-089888 · Präparat HOS-083941

14 Not known: Vaccine breakthrough infection (after in utero exposure to infliximab)*. Neoplasms benign, malignant and unspecified (including cysts and polyps) Rare: Lymphoma, non-Hodgkin’s lymphoma, Hodgkin’s disease, leukaemia, melanoma, cervical cancer. Not known: Hepatosplenic T-cell lymphoma (primarily in adolescents and young adult males with Crohn’s disease or ulcerative colitis), Merkel cell carcinoma, Kaposi’s sarcoma. Blood and lymphatic system disorders Common: Neutropenia, leucopenia, anaemia, lymphadenopathy. Uncommon: Thrombocytopenia, lymphopenia, lymphocytosis. Rare: Agranulocytosis (including infants exposed in utero to infliximab), thrombotic thrombocytopenic purpura, pancytopenia, haemolytic anaemia, idiopathic thrombocytopenic purpura. Immune system disorders Common: Allergic respiratory symptom. Uncommon: Anaphylactic reaction, lupus-like syndrome, serum sickness or serum sickness-like reaction. Rare: Anaphylactic shock, vasculitis, sarcoid-like reaction. Metabolism and nutrition disorders Uncommon: Dyslipidaemia. Psychiatric disorders Common: Depression, insomnia. Uncommon: Amnesia, agitation, confusion, somnolence, nervousness. Rare: Apathy. Nervous system disorders Very common: Headache. Common: Vertigo, dizziness, hypoaesthesia, paraesthesia. Uncommon: Seizure, neuropathy. Rare: Transverse myelitis, central nervous system demyelinating disorders (multiple sclerosis-like disease and optic neuritis), peripheral demyelinating disorders (such as Guillain-Barré syndrome, chronic inflammatory demyelinating polyneuropathy and multifocal motor neuropathy). Not known: Cerebrovascular accidents in close temporal association with infusion. Eye disorders Common: Conjunctivitis. Uncommon: Keratitis, periorbital oedema, hordeolum. Rare: Endophthalmitis. Not known: Transient visual loss occurring during or within 2 hours of infusion. Cardiac disorders Common: Tachycardia, palpitation. Uncommon: Cardiac failure (new onset or worsening), arrhythmia, syncope, bradycardia. Rare: Cyanosis, pericardial effusion. Not known: Myocardial ischaemia/myocardial infarction. Vascular disorders Common: Hypotension, hypertension, ecchymosis, hot flush, flushing. Uncommon: Peripheral ischaemia, thrombophlebitis, haematoma. Rare: Circulatory failure, petechia, vasospasm.

Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.

Vollständigen Kontext in der EMA-Fachinformation lesen →
Quellennachweis

Version 2025-12-15T13:59:00Z · SHA-256 3fe5ec643ebd8b47f3d2adf8a19ade1224c614e70c07c2d563b0cf68054693ab · Passage 397d32b1adbe1b57c526ade6394ce6783226dcd2d05aedd381cb033a39c00f59 · Zeichen 2567–6100 im Abschnitt

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.